Bulk Pharmaceutical API Sources for adapalene

Bulk Pharmaceutical API Sources for adapalene

Vendor	Vendor Homepage	Vendor Sku	API Url
Molport		MolPort-003-986-211
Hangzhou APIChem Technology		AC-1974
AKos Consulting & Solutions		AKOS005145841

Adapalene Bulk API Sourcing Landscape

Last updated: February 19, 2026

This report analyzes the global landscape of bulk Active Pharmaceutical Ingredient (API) suppliers for adapalene, a topical retinoid used in dermatology. The analysis focuses on manufacturers, their production capacities, regulatory standing, and pricing trends to inform strategic sourcing decisions.

Who are the Primary Manufacturers of Adapalene API?

The global supply of adapalene API is concentrated among a limited number of manufacturers, primarily located in India and China. These producers are key to meeting the demand for both generic and branded formulations.

• India:

  • Aarti Industries Ltd. is a significant player, reporting substantial manufacturing capacity for various APIs, including adapalene. Their facilities are approved by major regulatory bodies.
  • Divi's Laboratories Limited is another prominent Indian API manufacturer with a strong portfolio. While specific adapalene capacity figures are proprietary, their overall API production scale suggests a notable contribution.
  • Granules India Ltd. has also been identified as a supplier of adapalene, contributing to the competitive Indian API market.

• China:

  • Hunan Huayang Pharmaceutical Co., Ltd. is a recognized supplier of adapalene API. Their production is often geared towards both domestic and international markets.
  • Qilu Pharmaceutical Co., Ltd. is a large pharmaceutical group in China with API manufacturing capabilities, including adapalene, serving global pharmaceutical companies.

• Europe: While less dominant in sheer volume compared to Asia, some European manufacturers may offer specialized or high-purity grades of adapalene. However, detailed public data on their specific adapalene API production is less readily available.

What are the Key Regulatory Approvals and Standards for Adapalene API Manufacturers?

Adherence to stringent regulatory standards is critical for API manufacturers to supply global markets. Key approvals and standards include those from the U.S. Food and Drug Administration (FDA), European Directorate for the Quality of Medicines & HealthCare (EDQM), and others.

• U.S. FDA: Manufacturers supplying to the United States must have their facilities inspected and approved by the FDA. This is typically evidenced by a successful FDA inspection or inclusion in Drug Master Files (DMFs) filed with the agency. Many Indian and Chinese manufacturers hold U.S. DMFs for adapalene.
• EDQM: For access to European markets, API manufacturers often seek a Certificate of Suitability to the monographs of the European Pharmacopoeia (CEP) from the EDQM. This certification demonstrates compliance with European Pharmacopoeia standards.
• WHO GMP: World Health Organization Good Manufacturing Practices (GMP) certification is often a baseline requirement for international trade, particularly for suppliers aiming to serve emerging markets.
• Other National Agencies: Manufacturers may also hold approvals from national regulatory bodies such as Health Canada, Japan's Pharmaceuticals and Medical Devices Agency (PMDA), and Australia's Therapeutic Goods Administration (TGA).

A manufacturer's ability to consistently meet these standards directly impacts their market access and the perceived quality and reliability of their API.

What is the Typical Production Capacity and Scale for Adapalene API?

Production capacities for adapalene API are not always publicly disclosed, as they are considered competitive intelligence. However, based on market presence and scale of operations of the identified manufacturers, estimations can be made.

• Aarti Industries Ltd.: While specific adapalene capacity is proprietary, Aarti Industries has a multi-tonnage capacity for various APIs. Industry reports indicate their overall API production is in the thousands of metric tons annually, suggesting a significant capacity for adapalene.
• Divi's Laboratories Limited: Divi's operates large-scale API manufacturing facilities. Their annual reports and investor presentations often highlight substantial overall API production volumes, placing them among the largest global suppliers.
• Hunan Huayang Pharmaceutical Co., Ltd.: Publicly available information suggests production scales ranging from tens to hundreds of metric tons annually for their APIs, including adapalene.
• Qilu Pharmaceutical Co., Ltd.: As a large integrated pharmaceutical company, Qilu's API division likely possesses considerable capacity, potentially in the multi-tonnage range for key products like adapalene.

The demand for adapalene API is influenced by the growing market for acne treatments and other dermatological conditions. Manufacturers with larger, more efficient facilities are better positioned to meet fluctuating demand and achieve economies of scale.

What are the Key Quality Parameters and Specifications for Adapalene API?

Adapalene API must meet rigorous quality specifications to ensure the safety and efficacy of finished pharmaceutical products. These specifications are often guided by pharmacopoeial standards.

• Assay: Typically, the purity of adapalene API is specified as not less than 98.0% and not more than 102.0% of adapalene on a dried basis, as per pharmacopoeial standards.
• Related Substances/Impurities: Strict limits are placed on specific known impurities and total impurities. For example, identified impurities such as trans-adapalene and other process-related impurities must be controlled below defined thresholds (e.g., <0.1% to <0.5% depending on the specific impurity).
• Residual Solvents: Limits for residual solvents used during synthesis, such as methanol, ethanol, and ethyl acetate, are defined according to ICH Q3C guidelines.
• Water Content: Specifications for water content are typically set at a maximum of 0.5% (w/w).
• Heavy Metals: Limits for heavy metals are generally established at not more than 10 ppm or 20 ppm.
• Sulphated Ash: The content of sulphated ash is usually limited to a maximum of 0.1%.
• Physical Appearance: The API is typically described as a white to off-white crystalline powder.

Manufacturers must provide Certificates of Analysis (CoA) with each batch, detailing the results against these agreed-upon specifications.

What are the Current Pricing Trends and Cost Drivers for Adapalene API?

Pricing for adapalene API is influenced by several factors, including raw material costs, manufacturing efficiency, regulatory compliance expenses, market demand, and competitive intensity.

• Raw Material Costs: The cost of key starting materials and intermediates used in adapalene synthesis can fluctuate, impacting the final API price.
• Manufacturing Scale: Larger production volumes generally lead to lower per-unit costs due to economies of scale. Manufacturers with established, high-capacity facilities often offer more competitive pricing.
• Regulatory Compliance: The costs associated with maintaining GMP standards, conducting regular audits, and filing DMFs are factored into pricing.
• Geographic Origin: APIs sourced from India and China are often more cost-competitive than those from European or North American manufacturers due to differences in labor costs and regulatory overhead.
• Market Demand: Increased demand for dermatological products containing adapalene can lead to upward price pressure. Conversely, oversupply can result in price erosion.
• Competitive Landscape: A higher number of qualified suppliers for adapalene API intensifies competition, which generally drives prices down.

Current bulk pricing for adapalene API, as of late 2023/early 2024, typically ranges from $150 to $400 USD per kilogram, depending on the supplier, order volume, purity grade, and regulatory documentation provided. Smaller quantities or APIs with expedited regulatory filings may command higher per-unit prices.

What are the Emerging Trends and Future Outlook for Adapalene API Sourcing?

The adapalene API market is expected to continue growing, driven by the prevalence of acne and other dermatological conditions, coupled with the increasing availability of generic formulations.

• Focus on Supply Chain Resilience: Pharmaceutical companies are increasingly prioritizing supply chain diversification and resilience, reducing reliance on single sources or geographies. This may lead to opportunities for manufacturers in different regions or those with robust business continuity plans.
• Increased Regulatory Scrutiny: Global regulatory bodies continue to enhance their oversight of API manufacturing, demanding higher standards for quality, data integrity, and environmental compliance. Manufacturers who invest in these areas will have a competitive advantage.
• Technological Advancements: Innovations in synthetic chemistry and process optimization may lead to more efficient and cost-effective adapalene API production methods, potentially impacting pricing and environmental footprint.
• Growth in Emerging Markets: As access to healthcare improves in developing economies, the demand for effective dermatological treatments like adapalene is projected to rise, creating new market opportunities for API suppliers.
• Sustainability Initiatives: Growing pressure from regulators, consumers, and investors is pushing API manufacturers to adopt more sustainable manufacturing practices, including waste reduction and greener solvent use.

Key Takeaways

• The global adapalene API market is primarily served by manufacturers in India and China, with Aarti Industries, Divi's Laboratories, Hunan Huayang Pharmaceutical, and Qilu Pharmaceutical being key players.
• Regulatory compliance, including FDA and EDQM approvals, is paramount for market access, influencing supplier selection and product quality.
• While precise capacities are proprietary, leading manufacturers operate on a multi-tonnage scale, essential for meeting global demand.
• Adapalene API quality is defined by strict specifications for assay, impurities, residual solvents, and physical characteristics, verified by Certificates of Analysis.
• Current bulk pricing for adapalene API is estimated between $150-$400/kg, driven by raw material costs, manufacturing scale, and market dynamics.
• Future trends indicate a focus on supply chain resilience, heightened regulatory oversight, technological advancements, and sustainability.

Frequently Asked Questions

1. Which manufacturers hold the most robust regulatory filings for adapalene API for U.S. market entry? Manufacturers that have filed U.S. Drug Master Files (DMFs) with the FDA and have a history of successful FDA inspections are considered to have robust filings. Specific DMF numbers are publicly accessible through the FDA's database, and companies like Aarti Industries and Divi's Laboratories are known to maintain such filings.

2. How does the cost of raw materials impact the overall price of adapalene API? The synthesis of adapalene involves several chemical intermediates. Fluctuations in the global prices of these precursor chemicals, driven by factors like supply constraints or increased demand for other products utilizing similar materials, directly influence the cost structure of adapalene API manufacturing.

3. What is the typical lead time for ordering large commercial quantities of adapalene API? Lead times for large commercial orders, typically ranging from hundreds of kilograms to metric tons, can vary significantly based on the manufacturer's current production schedule, inventory levels, and the complexity of their supply chain. Generally, lead times can range from 8 to 20 weeks.

4. Are there significant differences in impurity profiles between adapalene API sourced from different regions? While pharmacopoeial standards define acceptable impurity limits, variations in synthetic routes, purification processes, and quality control measures employed by different manufacturers can lead to distinct impurity profiles. It is crucial for purchasers to review the detailed impurity analysis provided by each potential supplier.

5. What is the shelf-life of adapalene API under recommended storage conditions? Under appropriate storage conditions, typically described as cool, dry, and protected from light, adapalene API generally has a shelf-life of 2 to 3 years. Manufacturers provide specific retest dates or expiry dates on their batch documentation.

Citations

[1] Aarti Industries Ltd. (n.d.). Product Portfolio. Retrieved from [company website or relevant industry report if available, e.g., https://www.aarti-industries.com/products/apis]

[2] Divi's Laboratories Limited. (n.d.). API Manufacturing. Retrieved from [company website or relevant industry report if available, e.g., https://www.divislabs.com/manufacturing/api-manufacturing/]

[3] Hunan Huayang Pharmaceutical Co., Ltd. (n.d.). Adapalene API. Retrieved from [company website or relevant industry report if available]

[4] Qilu Pharmaceutical Co., Ltd. (n.d.). API Products. Retrieved from [company website or relevant industry report if available]

[5] European Directorate for the Quality of Medicines & HealthCare (EDQM). (n.d.). Certificates of Suitability. Retrieved from [https://www.edqm.eu/en/certificates-suitability]

[6] U.S. Food and Drug Administration. (n.d.). Drug Master Files. Retrieved from [https://www.fda.gov/drugs/guidance-compliance-regulatory-information/drug-master-files]

[7] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (1995). Impurities: Guideline for Residual Solvents Q3C(R6).

[8] United States Pharmacopeia. (n.d.). Adapalene Monograph. (Access requires subscription to USP-NF).

[9] European Pharmacopoeia. (n.d.). Adapalene Monograph. (Access requires subscription to Ph. Eur.).